MDLZ Stock Analysis: Mondelez International | NASDAQ

Confectioners | NASDAQ, USA | Market Cap: 77.366m USD | 12M Return: -11% | Charts, Fundamentals & Technical Analysis

Biscuits, Chocolates, Candies, Chewing Gum
Total Rating 53
Safety 66
Buy Signal -0.55
Confectioners
Industry Rotation: +9.1
Market Cap: 77.4B
Avg Turnover: 543M
Risk 3d forecast
Volatility23.3%
VaR 5th Pctl4.04%
VaR vs Median5.35%
Reward TTM
Sharpe Ratio-0.59
Rel. Str. IBD39.1
Rel. Str. Peer Group58.3
Character TTM
Beta-0.153
Beta Downside-0.107
Hurst Exponent0.443
Drawdowns 3y
Max DD29.00%
CAGR/Max DD-0.11
CAGR/Mean DD-0.27
EPS (Earnings per Share) EPS (Earnings per Share) of MDLZ over the last years for every Quarter: "2021-06": 0.66, "2021-09": 0.71, "2021-12": 0.71, "2022-03": 0.84, "2022-06": 0.67, "2022-09": 0.74, "2022-12": 0.73, "2023-03": 0.89, "2023-06": 0.76, "2023-09": 0.82, "2023-12": 0.84, "2024-03": 0.95, "2024-06": 0.86, "2024-09": 0.99, "2024-12": 0.65, "2025-03": 0.74, "2025-06": 0.73, "2025-09": 0.73, "2025-12": 0.72, "2026-03": 0.67,
EPS CAGR: -4.81%
EPS Trend: -56.0%
Last SUE: 1.36
Qual. Beats: 1
Revenue Revenue of MDLZ over the last years for every Quarter: 2021-06: 6642, 2021-09: 7182, 2021-12: 7658, 2022-03: 7764, 2022-06: 7274, 2022-09: 7763, 2022-12: 8695, 2023-03: 9166, 2023-06: 8507, 2023-09: 9029, 2023-12: 9314, 2024-03: 9290, 2024-06: 8343, 2024-09: 9204, 2024-12: 9604, 2025-03: 9313, 2025-06: 8984, 2025-09: 9744, 2025-12: 10496, 2026-03: 10080,
Rev. CAGR: 4.00%
Rev. Trend: 93.9%
Last SUE: 2.77
Qual. Beats: 2

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 10.5 years of data

Jan +1.3% 16
Feb -2.1% 13
Mar -2.6% 16
Apr +2.5% 53
May -0.3% 29
Jun -0.0% 0
Jul +1.9% 21
Aug -1.9% 26
Sep -1.2% 10
Oct -4.0% 23
Nov +2.4% 21
Dec +0.3% 8

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: MDLZ Mondelez International

Mondelez International is a global snack food and beverage company that manufactures, markets, and sells products across Latin America, North America, Asia, the Middle East, Africa, and Europe. Its product portfolio spans biscuits and baked snacks (such as cookies, crackers, salted snacks, snack bars, and cakes), chocolates, gums and candies, and a range of cheese, grocery, and powdered beverage items. The company markets globally recognized brands including Oreo, Ritz, LU, CLIF Bar, Cadbury Dairy Milk, Milka, and Toblerone.

The company distributes its products through a broad mix of retail channels, including supermarket chains, wholesalers, supercenters, club stores, convenience stores, drug stores, and e-retail platforms, using a combination of direct store delivery, company-owned warehouses, third-party distributors, and independent sales offices. It also sells directly to consumers through retailer digital platforms, its own websites, and social media. Mondelez was formerly known as Kraft Foods Inc. before adopting its current name in October 2012; it was incorporated in 2000 and is headquartered in Chicago, Illinois.

Mondelez operates within the Consumer Staples sector (Packaged Foods & Meats), a defensive industry category whose products tend to see stable demand across economic cycles. As a large-cap U.S.-listed company, it is widely held by institutional investors and benefits from a diversified geographic footprint that reduces reliance on any single regional market.

Headlines to Watch Out For
  • Cocoa and input cost inflation pressures chocolate margins
  • Emerging market FX headwinds weigh on Latin America revenue
  • Pricing actions offset volume softness in developed markets
Piotroski VR-10 (Strict) 5.5
Net Income: 2.61b TTM > 0 and > 6% of Revenue
FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.19 > 1.0
NWC/Revenue: -27.37% < 20% (prev -22.69%; Δ -4.68% < -1%)
CFO/TA 0.05 > 3% & CFO 3.89b > Net Income 2.61b
Net Debt (20.7b) to EBITDA (5.13b): 4.03 < 3
Current Ratio: 0.54 > 1.5 & < 3
Outstanding Shares: last quarter (1.29b) vs 12m ago -1.00% < -2%
Gross Margin: 28.77% > 18% (prev 32.74%; Δ -3.97% > 0.5%)
Asset Turnover: 56.13% > 50% (prev 52.90%; Δ 3.23% > 0%)
Interest Coverage Ratio: 6.15 > 6 (EBIT TTM 3.75b / Interest Expense TTM 610.0m)
Altman Z'' 1.63
A: -0.15 (Total Current Assets 12.7b - Total Current Liabilities 23.5b) / Total Assets 71.1b
B: 0.51 (Retained Earnings 36.3b / Total Assets 71.1b)
C: 0.05 (EBIT TTM 3.75b / Avg Total Assets 70.0b)
D: 0.57 (Book Value of Equity 25.8b / Total Liabilities 45.3b)
Altman-Z'' = 1.63 = BB
Beneish M -2.89
DSRI: 0.95 (Receivables 5.38b/5.26b, Revenue 39.3b/36.5b)
GMI: 1.14 (GM 32.74% / 28.77%)
AQI: 1.00 (AQ_t 0.66 / AQ_t-1 0.66)
SGI: 1.08 (Revenue 39.3b / 36.5b)
TATA: -0.02 (NI 2.61b - CFO 3.89b) / TA 71.1b)
Beneish M = -2.89 (Cap -4..+1) = A
What is the price of MDLZ shares?

As of July 24, 2026, the stock is trading at USD 60.05 with a total of 8,492,308 shares traded. Over the past week, the price has changed by +3.64%, over one month by +3.13%, over three months by +9.47% and over the past year by -10.99%.

Current recommended Stop Loss: 57.90 (which is 3.6% or 1.4 ATR below the current price).

Is MDLZ a buy, sell or hold?

Mondelez International has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy MDLZ.

  • StrongBuy: 11
  • Buy: 8
  • Hold: 9
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the MDLZ price?
Analysts Target Price 67.3 12%
Mondelez International (MDLZ) - Fundamental Data Overview as of 22 July 2026
Market Cap USD = 77.4b (77.4b USD * 1.0 USD.USD)
P/E Trailing = 30.2864
P/E Forward = 20.1613
P/S = 1.9684
P/B = 3.0409
P/EG = 1.0032
Revenue TTM = 39.3b USD
EBIT TTM = 3.75b USD
EBITDA TTM = 5.13b USD
Long Term Debt = 15.5b USD (from longTermDebt, last quarter)
Short Term Debt = 2.88b USD (from shortTermDebt, last quarter)
Debt = 22.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 598.0m
Net Debt = 20.7b USD (calculated: Debt 22.2b - CCE 1.52b)
Enterprise Value = 98.1b USD (77.4b + Debt 22.2b - CCE 1.52b)
Interest Coverage Ratio = 6.15 (Ebit TTM 3.75b / Interest Expense TTM 610.0m)
EV/FCF = 38.08x (Enterprise Value 98.1b / FCF TTM 2.58b)
FCF Yield = 2.63% (FCF TTM 2.58b / Enterprise Value 98.1b)
FCF Margin = 6.55% (FCF TTM 2.58b / Revenue TTM 39.3b)
Net Margin = 6.64% (Net Income TTM 2.61b / Revenue TTM 39.3b)
Gross Margin = 28.77% ((Revenue TTM 39.3b - Cost of Revenue TTM 28.0b) / Revenue TTM)
Gross Margin QoQ = 27.81% (prev 28.16%)
Tobins Q-Ratio = 1.38 (Enterprise Value 98.1b / Total Assets 71.1b)
Interest Expense / Debt = 2.75% (Interest Expense 610.0m / Debt 22.2b)
Taxrate = 24.60% (856.0m / 3.48b)
NOPAT = 2.83b (EBIT 3.75b * (1 - 24.60%))
Current Ratio = 0.54 (Total Current Assets 12.7b / Total Current Liabilities 23.5b)
Debt / Equity = 0.86 (Debt 22.2b / totalStockholderEquity, last quarter 25.8b)
Debt / EBITDA = 4.03 (Net Debt 20.7b / EBITDA 5.13b)
Debt / FCF = 8.04 (Net Debt 20.7b / FCF TTM 2.58b)
Total Stockholder Equity = 26.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.73% (Net Income 2.61b / Total Assets 71.1b)
RoE = 10.04% (Net Income TTM 2.61b / Total Stockholder Equity 26.0b)
RoCE = 9.06% (EBIT 3.75b / Capital Employed (Equity 26.0b + L.T.Debt 15.5b))
RoIC = 5.78% (NOPAT 2.83b / Invested Capital 49.0b)
WACC = 4.70% (E(77.4b)/V(99.6b) * Re(5.46%) + D(22.2b)/V(99.6b) * Rd(2.75%) * (1-Tc(0.25)))
Discount Rate = 5.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.80 | Cagr: -2.38%
[DCF] Terminal Value 73.10% ; FCFF base≈2.87b ; Y1≈2.52b ; Y5≈2.03b
[DCF] Fair Price = 9.31 (EV 32.6b - Net Debt 20.7b = Equity 11.9b / Shares 1.28b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -55.97 | EPS CAGR: -4.81% | SUE: 1.36 | # QB: 1
Revenue Correlation: 93.93 | Revenue CAGR: 4.00% | SUE: 2.77 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.68 | Chg30d=+0.37% | Revisions=+0% | Analysts=16
EPS next Quarter (2026-09-30): EPS=0.76 | Chg30d=-7.10% | Revisions=-57% | Analysts=16
EPS current Year (2026-12-31): EPS=3.05 | Chg30d=-0.14% | Revisions=-29% | GrowthEPS=+4.5% | GrowthRev=+3.5%
EPS next Year (2027-12-31): EPS=3.37 | Chg30d=-0.41% | Revisions=-17% | GrowthEPS=+10.5% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: -44% (up=3, down=10)